Armistice Capital’s Consumer and Retail Holdings Reflect Portfolio Diversification Beyond Healthcare Core
While Armistice Capital is primarily known among institutional investors for its healthcare and biopharma holdings, its 13F filings show a portfolio that extends into retail and consumer sectors as well. The fund, which manages more than $7 billion in assets, has disclosed positions in major retail chains and consumer companies alongside the specialty pharmaceutical stocks […]